- Reframe Daily
- Archive
- Page 3
Past Issues
Reframe Daily: Exercise after chemo boosts colon-cancer survival; lung & skin trials extend life + Walking Meditation
A 3-year exercise plan after chemo helped colon-cancer patients live longer; adding nivolumab before surgery improved 5-year survival in lung cancer; cemiplimab after surgery kept a tough skin cancer from coming back; an inhaled drug eased a rare lung disease; and a toripalimab plan without cisplatin worked with fewer side effects.
Reframe Daily: New wins in allergy, COVID antivirals, and gene editing + Christin's aspiration
New antibody shrank nose polyps; Paxlovid cut COVID faster than older drugs; gene editing fixed a blood enzyme in patient cells; tiny tags let doctors see transplanted cells in mice; and scientists found how a gut germ hurts the gut lining.
Reframe Daily: New immune target + mitophagy drug strengthen T cells; biopsy & blood tests speed cancer care
Peer-reviewed today: LAIR1-guided cell therapy boosts tumor control in mice; IL-17 targeting reduces calciphylaxis deposits in rats; a USP30 inhibitor prevents T-cell exhaustion; a single FFPE slide now shows proteins and genes; and a cell-free mRNA blood test flags immunotherapy-related myocarditis early.
Reframe Daily: Long-acting antibiotic clears infections; new insomnia drug; early SMA pill; infant polio vaccine
Dalbavancin simplified care for S. aureus bacteremia, seltorexant improved sleep in an RCT, presymptomatic risdiplam protected SMA infants, and a novel type-1 polio vaccine was safe and sparked strong immunity.
Reframe Daily: ER hep C screening works, low-cost lung rehab holds up, nasal COVID vaccine shows promise
Randomized trials support universal hep C testing in ERs and minimal-equipment pulmonary rehab; a combined education-plus-exercise plan eases chronic whiplash; a wearable sweat sensor enables at-home biomarker checks; and a measles/mumps-based intranasal COVID-19 vaccine protects in preclinical tests.
Reframe Daily: ER-targeting pill tops standard care; SCLC antibody beats chemo; oral Cipro works; kidney-drug duo cuts damage
Plus: a second oral breast-cancer drug shows benefit alone or with abemaciclib—this week’s trials point to simpler, stronger options across oncology and diabetic kidney disease.
Reframe Daily: New superbug-killer, diet-exercise cancer win, meditation rewires gaming addiction
Open for the lab-made antibiotic that crushes resistant germs, the off-and-on diet with weights that stalls breast cancer, meditation that rewires the gaming brain, a kidney-friendly probiotic, and gene testing that makes anxiety meds safer.
Reframe Daily: Heart Pill Reverses Damage, New Colon-Cancer “Smart Bomb,” Pig-Organ Clue & Mor
A well-known pill easing heart strain, an antibody-drug conjugate tackling late-stage colon cancer, insight that may make pig organs safe for people, a gene switch that stalls arthritis, and an mRNA HIV vaccine that sparks the right antibodies—all discovered today.